THE WOODLANDS, Texas, Dec. 4 /PRNewswire/ -- Lexicon Genetics Incorporated (NASDAQ:LEXG) announces Webcast, with the details described below.
What: Lexicon's senior management will provide a comprehensive update on
the company's clinical and preclinical programs at its Annual
Analyst and Investor Luncheon When: Tuesday, December 5, 2006 12:00 PM Eastern Where: Webcast link will be available at http://www.lexicon-genetics.com/
or at http://www.videonewswire.com/event.asp?id=36534 How: Live over the Internet -- Simply log on to the web at the address
above, or by using the link at Lexicon's website.
Contact: Bobbie Faulkner, (281) 863-3503 Lexicon Genetics is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon is systematically discovering the physiological and behavioral functions of genes to identify potential points of therapeutic intervention, or drug targets. Lexicon makes these discoveries using its proprietary gene knockout technology to model the physiological effects that could be expected from prospective drugs addressing these targets. For targets that the company believes have high pharmaceutical value, it engages in programs for the discovery and development of small molecule, antibody and protein drugs. Lexicon has advanced knockout-validated targets into drug discovery programs in six therapeutic areas: diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders and ophthalmic disease. Lexicon is working both independently and through collaborations and strategic alliances to accelerate the development and commercialization of its discoveries. Additional information about Lexicon is available through its corporate website, http://www.lexicon-genetics.com/.
Minimum Requirements to listen to broadcast: The Windows Media Player software, downloadable free from http://www.microsoft.com/ and at least a 56Kbps connection to the Internet. If you experience problems listening to the webcast, send an E-mail to: . http://www.videonewswire.com/event.asp?id=36534DATASOURCE: Lexicon Genetics Incorporated CONTACT: Bobbie Faulkner, +1-281-863-3503 Web site: http://www.lexicon-genetics.com/
|